Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2026-04-24 @ 3:58 PM
Study NCT ID:
NCT04730102
Status:
COMPLETED
Last Update Posted:
2021-02-10
First Post:
2021-01-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rectal Washout in Transanal Total Mesorectal Excision and Presence of Intraluminal Malignant Cells
Sponsor:
Slagelse Hospital
Organization:
Study Overview
Official Title:
Rectal Washout in Transanal Total Mesorectal Excision and Presence of Intraluminal Malignant Cells
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study aims to assess the existence of intraluminal malignant cells and the appropriate fluid volume needed to perform rectal washout during transanal total mesorectal excision (taTME) for rectal cancer.
Detailed Description:
Twenty patients undergoing taTME for rectal cancer is included. Following the closure of the rectal lumen by a purse string suture, rectal washout is performed with a total of 500 ml sterile water. Fluid samples are collected after every 100 ml by instilling 50 ml of saline after each washout. A sixth sample is collected from the presacral cavity. Each sample is cytologically examined by a pathologist and labelled either malignant or non-malignant.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: